AVO

Hardman & Co

Advanced Oncotherapy Preparing for commercialisation

Advanced Oncotherapy (LON:AVO) goal is to deliver an affordable and novel proton beam therapy system (PBT), based on state-of-the-art technology developed originally at the world-renowned CERN. 2018 was characterised by

Hardman & Co

Advanced Oncotherapy Four components integrated

Advanced Oncotherapy (LON:AVO)  goal is to deliver an affordable and novel proton therapy system (PT), based on state-of-the-art technology developed originally at the world-renowned CERN. Achievement of major technical milestones

Advanced Oncotherapy Plc

University Hospitals hitting mark with proton therapy

While some proton therapy centres across the country have reportedly struggled to stay profitable, officials at University Hospitals say they’ve found the “sweet spot” two years after the Cleveland-based health

Advanced Oncotherapy Plc

Advanced Oncotherapy a Significant Year

Nicolas Serandour, CEO of Advanced Oncotherapy, said: “The technological development of our LIGHT system remains on-track and we continue to proceed with a significantly reduced overall technology risk profile. Similarly

Advanced Oncotherapy Plc

CERN Technology Next Generation Cancer Treatment

STFC and Advanced Oncotherapy (LON:AVO) are collaborating in the construction of a proton therapy assembly and test facility at STFC’s Daresbury Laboratory, that will build on the technology at the

Advanced Oncotherapy Plc

Proton Beam therapy to come to Isarel

The deputy Health Minister Yaakov Litzman has ordered his ministry to finalise plans to establish a Proton Beam Therapy center in Israel. The announcement came after Litzman returned to Israel